Scripta Therapeutics
Drug discovery platform using transcription factor mapping and AI models to find neurodegenerative disease therapies
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-10-30
About Scripta Therapeutics
Scripta Therapeutics is a techbio company that develops drugs by targeting transcription factors, the master controllers of biology. Its approach maps transcription factors across the genome in disease, identifies and predicts molecules that modulate them, and validates results in patient-derived models. Its first focus is neurodegenerative diseases such as Alzheimer's, Parkinson's and ALS.
Its investors include Oxford Science Enterprises and Apollo Health Ventures, both represented on its board.
Scripta is headquartered in Oxford, United Kingdom, and was founded in 2024. Its leadership includes CEO and founder Peter Hamley and academic co-founder Prof. Noel Buckley. The company lists open roles for technologists and scientists.
Product: Transcription factor-targeted drug discovery pipeline for neurodegenerative diseases, combining AI/ML models with patient-derived model validation.
Jobs at Scripta Therapeutics
More biotech & pharma companies
Sisaf
RNA drug-delivery platform licensed to pharma partners, with a research reagent for labs plannedNew on EvolcSitala Bio
Develops medicines targeting harmful inflammation for patients with neurodegenerative and inflammatory diseasesNew on EvolcSmartway Pharmaceuticals
Pharmaceutical wholesaling and specialist medicine supply for healthcare providers, pharmaceutical companies and aid organizationsNew on EvolcSolasta Bio
Develops peptide-based precision insecticides for growers and agricultural businesses seeking crop protectionNew on EvolcSPT Labtech
Lab automation instruments for liquid handling and sample management, sold to life science research laboratoriesSpur Therapeutics
Develops gene therapies for people with chronic and debilitating diseasesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Framer
- Google Analytics 4